Evidence map›Paper›PMID 38190701›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.

Michael B Keller, Xin Tian, Moon Kyoo Jang, Rohan Meda, Ananth Charya, Gerald J Berry, Charles C Marboe, Hyesik Kong, Ileana L Ponor, Shambhu Aryal and 4 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Review
  3. Donor-derived cell-free DNA associated with increased risk of chronic lung allograft dysfunction and mortality: Are absolute levels better than percentage?The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Observational
  4. Article
  5. Article
  6. Article
  7. Respiratory oscillometry in monitoring lung transplant allograft function: a systematic scoping review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Article
  8. Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Observational
  9. Article
  10. Article
  11. %dd-cfDNA: The New Frontier for Heart/Lung Transplant Surveillance?Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  12. Article
  13. Reply to Glanville: The Emperor's New Clothes Revisited.American journal of respiratory and critical care medicine · 2024
    Article
  14. The Emperor's New Clothes Revisited.American journal of respiratory and critical care medicine · 2024
    Article
  15. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  16. Article
  17. Article
  18. Antibody-Mediated Rejection in Lung Transplantation: Diagnosis and Therapeutic Armamentarium in a 21st Century Perspective.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Michael B KellerGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Xin TianOffice of Biostatistics Research, NHLBI, NIH, Bethesda, Maryland.
Moon Kyoo JangGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Rohan MedaLaboratory of Applied Precision Omics and.
Ananth CharyaUniversity of Maryland Medical Center, Baltimore, Maryland.
Gerald J BerryGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Charles C MarboeGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Hyesik KongGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Ileana L PonorDepartment of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland; and.
Shambhu AryalGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Jonathan B OrensGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Pali D ShahGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Steven D NathanGenomic Research Alliance for Transplantation, Bethesda, Maryland.
Sean Agbor-EnohGenomic Research Alliance for Transplantation, Bethesda, Maryland.ORCID 0000-0002-9380-9161
Johns Hopkins University · USApplied Precision (Slovakia) · SKCenter for Genomic Science · ITInova Fairfax Hospital · USCancer Research And Biostatistics · USUniversity of Maryland, Baltimore · US

Funding

Cystic Fibrosis Foundation AGBORE20QI0National Heart, Lung, and Blood Institute Division of Intramural ResearchNIH Distinguished Scholar Program
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft RejectionLung TransplantationAcute DiseaseAdultAgedAllograftsCell-Free Nucleic AcidsCohort StudiesFemaleHumansMaleMiddle AgedProportional Hazards ModelsProspective StudiesRisk FactorsCell-Free Nucleic Acidstransplantation

Identifiers

PMID38190701
PMCPMC11146548
OpenAlexW4390660542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.